ENTITY
Sun Pharmaceutical Industries

Sun Pharmaceutical Industries (SUNP IN)

172
Analysis
Health CareIndia
Sun Pharmaceutical Industries Limited manufactures and markets pharmaceuticals for domestic and international distribution. The Company's pharmaceutical portfolio includes drugs in the areas of diabetes, cardiology, neurology, psychiatry and gastroenterology.
more
bearishMSCI ACWI Index
23 Apr 2020 20:58

Global Equity Rally Losing Upside Momentum

The global rally appears to be losing steam as the bearish rising wedge patterns we highlighted last week in the MSCI ACWI, ACWI ex-US, EM, and...

Logo
414 Views
Share
08 Apr 2020 14:15

TPG and KKR in Race to Buy 20% Stake in Piramal’s Pharma Business Valued Over US$2bn

It was reported by several news media outlets that the US PE giants, TPG Capital or KKR may acquire a 20% stake in India’s Piramal Enterprises...

Share
29 Jan 2020 07:51

EM Pullback Opportunity

Supporting our global bull market thesis, uptrends remain intact for the major global indexes (MSCI ACWI, ACWI ex-US, EAFE, and EM). At this point,...

Logo
416 Views
Share
08 Mar 2019 11:33

India Generic Drugs: "Antitrust Unredacted"

New information in the government's investigation into antitrust violations by generic drug companies continues to surface. An unredacted version...

Share
13 Dec 2018 12:54

India On Ground: Local Fund Managers Still Debate Valuations,OK with News Flow but Expect Volatility

Last few months have been stressful for domestic fund managers and more than the sudden market movement, much increased volatility even in large...

Logo
524 Views
Share
x